Which patients stop working because of rheumatoid arthritis? Results of five years' follow up in 732 patients from the Early RA Study (ERAS).
about
A structured literature review of the burden of illness and unmet needs in patients with rheumatoid arthritis: a current perspectiveRheumatoid Arthritis Disease Activity Is Determinant for ABCB1 and ABCG2 Drug-Efflux Transporters FunctionA mixed methods protocol to investigate medication adherence in patients with rheumatoid arthritis of White British and South Asian originUsing intervention mapping (IM) to develop a self-management programme for employees with a chronic disease in the Netherlands.Physical function improvements and relief from fatigue and pain are associated with increased productivity at work and at home in rheumatoid arthritis patients treated with certolizumab pegolPaid work is associated with improved health-related quality of life in patients with rheumatoid arthritisThe impact and burden of chronic pain in the workplace: a qualitative systematic review.Exploring lifetime occupational exposure and SLE flare: a patient-focussed pilot study.Impact of morning stiffness on working behaviour and performance in people with rheumatoid arthritis.Health Assessment Questionnaire disability progression in early rheumatoid arthritis: systematic review and analysis of two inception cohortsEfficacy & safety evaluation of Ayurvedic treatment (Ashwagandha powder & Sidh Makardhwaj) in rheumatoid arthritis patients: a pilot prospective study.Predictive factors of work disability in rheumatoid arthritis: a systematic literature reviewProductivity costs among patients with rheumatoid arthritis: the influence of methods and sources to value loss of productivity.Long term safety of etanercept in elderly subjects with rheumatic diseases.Work disability among two cohorts of women with recent-onset rheumatoid arthritis: a survival analysisEpidemiology and burden of illness of rheumatoid arthritis.Overview of work disability in rheumatoid arthritis patients as observed in cross-sectional and longitudinal surveys.The future of rheumatoid arthritis and hand surgery - combining evolutionary pharmacology and surgical techniqueProtocol for a randomised controlled trial for Reducing Arthritis Fatigue by clinical Teams (RAFT) using cognitive-behavioural approaches.Systematic review of studies of productivity loss due to rheumatoid arthritis.Tacrolimus in rheumatoid arthritis.Work disability in scleroderma is greater than in rheumatoid arthritis and is predicted by high HAQ scores.The impact of using musculoskeletal ultrasound imaging and other influencing factors on medication adherence in patients with rheumatoid arthritis: a qualitative study.A systematic review of infliximab in the treatment of early rheumatoid arthritis.The impact of rheumatoid arthritis and biologics on employers and payers.Benefit of anti-TNF therapy in rheumatoid arthritis patients with moderate disease activityThe clinical efficacy and safety of certolizumab pegol (CZP) in the treatment of rheumatoid arthritis: focus on long-term use, patient considerations and the impact on quality of lifeWork disability and state benefit claims in early rheumatoid arthritis: the ERAN cohort.The Short Form Score for the Assessment and Quantification of Chronic Rheumatic Affections of the Hands in Daily Clinical Routines-Its Sensitivity to Change and Preliminary Patient Relevant Variation Values: A Pilot Study.Rheumatoid arthritis: the role of early intervention and self-management.The clinical efficacy and safety of certolizumab pegol in rheumatoid arthritis.Effect of panchakarma and Ayurvedic treatment in postpartum rheumatoid arthritis (amavata): A case study.The efficacy and safety of golimumab in the treatment of arthritis.RAPID and FAST4WARD trials: certolizumab pegol for rheumatoid arthritis.Dose modification of anti-TNF in rheumatoid arthritis and estimated economical impact: a review of observational studies.Biological nurse specialist: goodwill to good practice.Skin Signs of Rheumatoid Arthritis and its Therapy-Induced Cutaneous Side Effects.Estimated medical expenditure and risk of job loss among rheumatoid arthritis patients undergoing tofacitinib treatment: post hoc analyses of two randomized clinical trials.Correlates and predictors of disability in vulnerable US Hispanics with rheumatoid arthritis.Effect of adalimumab on the work-related outcomes scores in patients with early rheumatoid arthritis receiving methotrexate.
P2860
Q26770099-D4A3348C-E196-44F9-A480-0A6B52D8F1C7Q28552801-B54329E2-39E5-4BF4-8774-52E7E7C6D056Q30537006-10B27715-2158-4F8A-80A2-95C5308787B4Q33611373-E59950BF-FD7E-4442-A5BD-F30D44FED9D4Q34117111-EB183A56-0CED-4B96-A614-B2760912F9C3Q34143404-009CB253-8989-44AD-AD81-DDD2E9D02998Q34214315-3C409ABF-85FB-404A-828C-59E613AC8A71Q34424649-3341DA9F-FED5-475F-AE26-4913F460D940Q34545029-E6786022-672D-414B-A80A-A681840C4EDFQ34805081-F302728C-019B-4070-ADAB-338E73BD7F46Q35520129-52925BE3-7328-4E93-8B66-937EC41280AFQ35553588-94C571F3-68AF-4A2E-852E-EC9DF442A6FAQ35555089-0D88AAC8-2A84-4500-BB5B-22C82A49BCD6Q35636875-8B915A07-2B20-4AD9-93BF-CE489477FB34Q35754388-A259FE28-145F-4C3F-9F3A-0411013806FBQ35780338-0A91C2ED-915A-4959-AB5C-ACD7E835785CQ35799592-6992F3DA-BB48-4E44-B0DC-81E612C8F436Q35810276-94E319DA-C2DD-4567-951D-F8A95063E152Q35960090-AA9BA8D1-1E4D-4921-B63F-6203D626EF78Q36312507-0B41AC47-5443-46A6-956E-30593AF17FD8Q36349618-125F31EC-CB37-4B59-903A-74F05AB51CCDQ36985736-A84034F9-4D6D-42C8-9B42-EED9FDDD242FQ37021230-527BA398-E5ED-49FC-92C3-9845619EABBFQ37160391-0CB42E91-4C90-458F-9447-F6983D5649CCQ37251489-69B19663-042E-4A2E-930B-63C92C730183Q37347655-DF36867B-D973-4D64-A818-CB7D8B13E6E2Q37358093-303FA57C-4E4B-4AA2-A4BB-58F02E3EB802Q37595991-0DB5CA63-94C3-4E37-830D-13F0124D9B5AQ37609311-CB6224AB-41B6-4D9F-85B4-E555C5EDBEC8Q37645975-5CB02D9B-F33D-4B5C-815D-1D7E4A7EC529Q37709364-52129469-7112-4070-A534-D9E2D3ECAED8Q37734920-15E65881-017E-48B3-8DBE-AC2AC21E7155Q37760938-F81A5760-22BF-4812-BF18-EF7D638649D2Q37786625-E9EA9760-8F06-4A6A-8F4E-6899006FC7B0Q38306139-FCFF262A-3E4B-4BC5-BD88-0F28B36D18EAQ38429514-ED8B1831-0543-4B3A-B04C-6252B9BD2069Q38663608-F215A25D-3B47-4290-8113-8F799DB30E62Q38689012-EE0639AE-F41A-4C86-8EC9-BEE9A78C2CBBQ39631082-AD2E71B8-B459-4EF4-BCE4-1A3A80ADDABAQ39821943-D79DF407-A25D-43F5-8447-7ACD62A58C16
P2860
Which patients stop working because of rheumatoid arthritis? Results of five years' follow up in 732 patients from the Early RA Study (ERAS).
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Which patients stop working be ...... rom the Early RA Study (ERAS).
@ast
Which patients stop working be ...... rom the Early RA Study (ERAS).
@en
Which patients stop working be ...... rom the Early RA Study (ERAS).
@en-gb
type
label
Which patients stop working be ...... rom the Early RA Study (ERAS).
@ast
Which patients stop working be ...... rom the Early RA Study (ERAS).
@en
Which patients stop working be ...... rom the Early RA Study (ERAS).
@en-gb
prefLabel
Which patients stop working be ...... rom the Early RA Study (ERAS).
@ast
Which patients stop working be ...... rom the Early RA Study (ERAS).
@en
Which patients stop working be ...... rom the Early RA Study (ERAS).
@en-gb
P2093
P2860
P356
P1476
Which patients stop working be ...... rom the Early RA Study (ERAS).
@en
P2093
Kulinskaya E
Williams P
Winfield J
P2860
P304
P356
10.1136/ARD.61.4.335
P407
P50
P577
2002-04-01T00:00:00Z